WELL continues to focus on integrating and streamlining its operating businesses and is pleased to provide a number of related updates that supports its goal of improved profitable growth. All of… Read More
IPON to grant PharmAla an initial grant of $35,000, with a further total grant of $100,000 available in subsequent funding calls VANCOUVER, BC – PharmAla Biotech Holdings Inc. (“PharmAla” or… Read More
Fourth-Quarter revenues of $2.41 billion, up 10% on a Reported basis and up 4% on an Organic1 basis Full-Year revenues of $8.76 billion, up 8% on a Reported basis and 7%… Read More
SILVER SPRING, MD & RESEARCH TRIANGLE PARK, NC – United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced its financial results for the quarter and year ended December 31,… Read More
VANCOUVER, BC – NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, has been recognized by… Read More
